Beat growth, held guidance, Cryptas unproven — the caution beneath the headline
eMudhra reported 29.5% revenue and 27.9% PAT growth, crushing guidance. But management held full-year guidance, and the sequential quarter declined 1.4%. The beat is real; the confidence isn't.
₹32.0 Cr
+27.9% YoY
25%
Beats 15–18% prior guidance
−1.4%
₹190.7 Cr vs. implied ₹193.4 Cr Q4
18% organic
Unchanged despite 25% Q1 organic
The tension: strong beat, flat guidance, silent softness
On the surface, Q1 looks like a rout — revenue and PAT both beat the prior 15–18% and 25–30% guidance by wide margins. But here's what management's flatness signals: they see headwinds ahead. The real clue sits in the sequential number. Reported revenue was ₹190.7 Cr; Q4 FY26 must have been roughly ₹193.4 Cr, making this quarter down 1.4% QoQ. Trust Services accounts for a ₹5–7 Cr drag (token de-stocking), leaving ₹1–2 Cr of unexplained softness. Management didn't mention the QoQ decline on the call. That omission is the story.
Where the growth came from
The 29.5% revenue growth masks a split: organic growth of ~25% and inorganic contribution of ~4.5% from Cryptas, which contributed ₹20 Cr (11.6% of quarterly revenue) in its first full quarter post-acquisition. Enterprise Solutions organic growth of 25% is solid and outpaced the old 15–18% guidance. But the company buried the lead by lumping it into a 50% headline number that includes the Cryptas boost. Separating signal from noise is critical here.
Revenue grew 28% YoY, EBITDA margin ~40%+ YoY
Revenue +29.5% YoY; EBITDA margin 26.2% (flat QoQ, flat YoY)
Supported on revenue; EBITDA claim unsubstantiated
Enterprise Solutions grew 50% YoY, Services 5% YoY
Enterprise +50% (25% organic + ~25% inorganic Cryptas); Services +5% organic
Supported; organic breakout required to see true momentum
Trust Services decline is temporary; recovery expected by September
Quantified ₹5–7 Cr token volume loss (~3% of revenue); margin impact minimal (10% gross margin on tokens); recovery assumes FIPS 140-3 compliance by Sep 2026
Partial; headwind quantified, but Q2 recovery timing unconfirmed
Cryptas will be profitable in FY27
Cryptas revenue ₹20 Cr; B.V. losses still ₹4 Cr; two customer wins (German data center, Austrian municipality) validate product substitution strategy but don't prove scale
Overstated; wins are validating signals, not proof of profitability turnaround
International margin headwinds will be offset by Cryptas profitability and volume growth
International segment margin ~20% (vs. 26% domestic) in Q1; driven by Cryptas losses + senior hire costs (USD 200–300k per hire). Cryptas path to profitability contingent on customer wins
Overstated; relies on unproven Cryptas turnaround
What changed on this call
Three material shifts from prior guidance:
3-year PAT doubling articulated for the first time — Management formally disclosed a target to 2x PAT by FY29 (implying ~₹220 Cr from a FY26 base of ~₹110 Cr) via 18–20% organic revenue growth + margin expansion to 17–18%. This is a quantified vision, not earlier hand-waving.
Cryptas first wins validate the integration strategy — German data center and Austrian municipality customers now buying eMudhra product stack (CertiNext CLM, emSigner) instead of third-party Keyfactor licenses. Early signals of product substitution, but two wins are not proof of model.
Trust Services headwind quantified at ₹5–7 Cr, characterized as temporary — Margin impact minimal (~10% gross margin on tokens means ~₹0.5–0.7 Cr PAT drag, not material). Recovery expected after Sep 2026 FIPS 140-3 token transition.
New product launches disclosed (PrivaTrust, CBOM, AI-emSigner) but revenue impact unquantified — PrivaTrust (consent management, DPDP Act compliance) commercially live with pilots underway. CBOM analysis added to CertiNext for PQC transition. Impact vague; management says visibility in '1–2 quarters.'
The bull-bear ledger
Organic enterprise growth of 25% outpaces prior 15–18% guidance; product mix shift is real and margin-accretive
Operating margins stable at 26% EBITDA, 16.6% PAT despite Cryptas losses and international drag; quality earnings
Trust Services TAM still large; 3-year recovery roadmap plausible if FIPS 140-3 and new tokens execute on time
Cryptas first wins in Germany and Austria early validation of product substitution model; European cross-sell TAM real
Sequential revenue decline of 1.4% QoQ not disclosed and unaddressed; signals underlying softness beneath headline YoY
Cryptas still loss-making (₹4 Cr subsidiary losses); path to profitability contingent on customer wins, not structural
International segment margin dilution (20% vs 26%) driven by Cryptas + senior hires; recovery timing murky
Guidance held at 18% organic / 25% PAT despite beating both in Q1; suggests management expects headwinds or is being conservative on visibility
New products (PrivaTrust, CBOM, AI-emSigner) early-stage with unquantified TAM; Agentic AI opportunity called structural but revenue still zero
1
HighCryptas profitability contingency — ₹4 Cr losses embedded; only two early wins
Integration success hinges on customer adoption of eMudhra product stack over third-party alternatives. Two wins validate strategy but don't prove scale or timeline to profitability in FY27. If wins don't accelerate, the ₹4 Cr annual drag persists; P&L impact is material.
2
MediumTrust Services recovery timing uncertain — ₹5–7 Cr headwind extends into Q2 at minimum
Management says 'top-line may continue to be less' in Q2, but no specific recovery date given. Assumes Sep 2026 FIPS 140-3 compliance and new token adoption on schedule. Slippage here risks a second quarter of sequential softness; momentum narrative breaks.
3
MediumSequential revenue decline (−1.4% QoQ) unaddressed on call
Trust Services explains ₹5–7 Cr, leaving 1–2% of unexplained softness. Not mentioning QoQ decline is a red flag for selective disclosure. Points to possible demand headwind beneath headline YoY growth; requires monitoring.
4
MediumInternational margin dilution (20% vs 26% domestic) dependent on Cryptas + volume scale
Margin gap driven by Cryptas losses + senior hires (USD 200–300k each). Timeline to profitability not specified. If Cryptas doesn't turn profitable by end of FY27, the 20% international margin persists, capping overall EBITDA upside.
5
MediumNew product adoption uncertainty — PrivaTrust, CBOM, AI-emSigner all early-stage
PrivaTrust (DPDP Act compliance, India focus) launching with pilots; international timeline vague. CBOM (PQC transition) and AI-emSigner still in pilots. Unquantified revenue impact; timing to meaningful contribution unclear. Hype-risk if TAM doesn't materialize.
6
MediumFII / DII institutional trimming despite quarter beat
FII down 103 bps QoQ to 3.13%; DII down 341 bps to 13.34%. Institutions pulling back suggests valuation concern or execution doubt despite strong reported numbers. Lack of buying support on a beat is a bearish signal for near-term momentum.
7
LowAgentic AI TAM realization risk — currently zero revenue, early conversations only
Structural tailwind is real (AI agents require identity/traceability infrastructure), but monetization timeline is vague and M&A in this space competitive/expensive. Near-term impact negligible; long-term optionality real but unproven.
How the street is positioned
The market's verdict was restrained. On announcement day (July 29), the stock barely moved (+0.47%, delivery 45.4%) despite beating revenue and PAT growth targets. By day 3, it had drifted higher to +5.16%, suggesting the beat registered but without conviction. Today at ₹477.85, the stock trades 30.58% below its all-time high and 30.81% above its 52-week low — stationary in both range. That drawdown from ATH is justified caution: the stock priced in a 2x PAT vision before Cryptas integration risk was fully visible, and the Q1 sequential decline (even if unacknowledged on the call) has caught the market's attention.
Institutional flows are pulling back, not adding. FII ownership fell to 3.13% (down 103 bps QoQ), and DII slipped to 13.34% (down 341 bps). That dual-trim despite a headline beat tells you institutions are skeptical of sustainability. Either they see the sequential softness as a signal of demand weakness, or they're marking down the odds that Cryptas executes on time. The Bellwether Capital bulk buy in March 2026 at ₹391 (now worth ₹477, a +21.7% unrealized gain) shows selective smart money still in the name, but at lower conviction than the broader DII base.
Valuation context: At ₹477.85 on Q1 PAT of ₹32 Cr (annualized ~₹128 Cr on reported, ~₹105 Cr on organic), the stock is roughly 3.7x annualized reported earnings. If FY27 guidance of 25% PAT growth holds, that's ₹160 Cr PAT (reported), implying a forward P/E of ~14.9x. Fair to slight premium for a compounder with 25%+ organic growth, but not compelling when guidance flatness + institutional trimming signal execution risk. The 30% drawdown from ATH has brought valuation back to reasonable, not cheap.
What to watch next
1 · Q2 FY27 organic revenue growth (ex-Cryptas)
Is 25% sustainable, or does Q2 return to 15–18% range? If sequential revenue improves and organic stays above 20%, the caution is overdone. If it drops below 15%, the beat was Q1-specific (Cryptas boost), and the 18% guidance is at risk.
2 · Trust Services recovery pace post-Sep 2026 FIPS 140-3 transition
Can eMudhra ramp new token production and close the ₹5–7 Cr volume gap by Q3? If recovery is clean and linear, that removes a 3-point headwind from FY27 guidance. Delay signals tighter market, supply constraints, or adoption friction on new tokens.
3 · Cryptas customer win pipeline and path to profitability
Two early wins (Germany, Austria) are green lights; the next 4–6 quarters will show whether European enterprise is buying the model. If Cryptas reaches profitability by end of FY27, the international segment margin recovery story is on track. If not, the ₹4 Cr drag is structural and FY28 upside is capped.
The debate
The verdict
Rating: Hold. Confidence: 6/10.
eMudhra delivered a beat on organic growth (25% vs. 15–18% guidance) with stable margins, but the sequential decline, held guidance, and unproven Cryptas profitability tell a cautious story beneath the headline. The market has priced in some skepticism (stock down 30% from ATH, FII/DII trimming), and at current valuation (3.7x annualized earnings, 14.9x forward P/E), there's no margin of safety. The next two quarters will confirm whether the beat is sustainable or Q1-specific. Until then, the stock is fairly valued as a steady compounder, not a re-rating candidate.
The single number to track from here: organic revenue growth in Q2 FY27. If it stays above 20%, confidence in the FY27 guidance rises and the bear case weakens. If it drops below 15%, the quarter was Cryptas-inflated and structural headwinds are deeper.
eMudhra is executing the plan — organic growth is solid, margins are holding, Cryptas early wins are validating, and the 3-year 2x PAT vision is credible. But execution risk is real: Trust Services recovery is assumed, not confirmed; Cryptas profitability is contingent on customer wins, not structural; and new products are early-stage. The stock's 30% drawdown from ATH has brought it back to fair value, not deep value. Hold and monitor — the next 2–3 quarters will tell whether this is a buying setup or a warning signal.
eMudhra Q1: consolidated PAT ₹32 Cr, +28% YoY as Cryptas lifts revenue 29%
PAT +27.86% YoY · revenue +29.47% · margins compressing
₹190.72 Cr
+29.47% YoY
₹32 Cr
+27.86% YoY
16.63%
0pp YoY
₹3.91
eMudhra reported consolidated Q1 FY27 revenue of ₹190.7 Cr, up 29.5% YoY from ₹147.3 Cr, with net profit of ₹32.0 Cr, up 27.9% YoY from ₹25.0 Cr — a clean print with no exceptional items on either side. Sequentially revenue slipped 1.4% off a seasonally strong ₹193.4 Cr March quarter, but PAT rose 8.2% QoQ, and basic EPS improved to ₹3.91 from ₹3.05 a year ago. The bulk of the topline lift is inorganic: the international Enterprise-Trust business (which now houses the consolidated Cryptas/European entities) contributed ₹125.5 Cr of the ₹190.7 Cr revenue, and the newly folded-in subsidiaries show up in a 6x jump in finance costs (₹1.2 Cr vs ₹0.2 Cr) and a 78% rise in depreciation (₹12.0 Cr vs ₹6.7 Cr).
Q1 FY-2027 vs prior quarters
That integration cost is where the margin story sits: operating margin compressed to ~20.6% from ~23.5% a year ago (and 21.7% in Q4), even as net margin held roughly flat at ~16.8% (vs 16.6% YoY) — so the squeeze is at the operating line from acquired-business D&A and interest, not at the bottom line. The standalone entity (India parent) grew more modestly — revenue ₹66.1 Cr (+14.4% YoY) and PAT ₹12.4 Cr (+21.3% YoY) — underlining that the consolidated growth is being driven by the overseas/subsidiary stack rather than the core India CA business.
The stock went into the print at ₹454.4, up 3% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters.
What the summary numbers don't show
Results unaudited, limited-review by Suri & Co with unmodified conclusion — approved by board July 29, 2026
Management guides for 15-18% organic revenue growth and 25-30% PAT growth in FY27, driven by an increasing mix of higher-margin product sales. The company is focused on product-led growth fueled by cybersecurity trends like AI and PQC, international expansion, and DPI deployments. Strategically, the company announced a
— This quarter: met
Against management's May guidance of 15-18% organic revenue growth and 25-30% PAT growth for FY27, the ₹32 Cr PAT (+28%) lands squarely inside the profit band, confirming the confident tone from the Q4 concall; the reported +29.5% revenue is flattered by the Cryptas consolidation, so the organic pace needs the July 30 earnings call to verify. No brokerage consensus is published for this small/mid-cap, so the print can't be graded against a formal Street number. The board approved the results on July 29; a dividend record date was set for June 18 earlier in the quarter, and the company picked up ESG scores (SES 68, Crisil ESG 60) during Q1.
W1
Organic vs inorganic revenue split at the July 30 earnings call — is core growth inside the guided 15-18% band ex-Cryptas?
W2
Operating margin trajectory: whether ~20.6% OPM recovers as acquired D&A/finance costs normalise, or stays diluted
W3
PAT run-rate vs the 25-30% FY27 guidance and the stated 3-year PAT-doubling goal after a ₹32 Cr Q1
Source in INR million; converted to Cr (÷10). No exceptional items. Consol PAT 31.997 Cr is after associate loss (−0.018 Cr); owners' share 32.146 Cr, NCI −0.149 Cr. Finance cost (11.96mn vs 2.01mn YoY) and D&A (119.78mn vs 67.26mn) up sharply from Cryptas/subsidiary consolidation.
Beat growth, flat guidance masks Q1 weakness, Cryptas unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met FY27 organic growth expectation (25% organic in Q1 vs. 15–18% guide), but Trust Services headwind and Cryptas still loss-making reduce near-term conviction.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 beat growth estimates (29.5% revenue, 27.9% PAT) but management maintained guidance (18% organic, 25% PAT), signaling caution. Trust Services decline (-₹5–7 Cr) extends into Q2; Cryptas profitability hinges on early-stage product substitution wins. Long-term 2x PAT vision credible but relies on margin expansion and unproven new products (PrivaTrust, CBOM).
₹190.7 Cr
Revenue · +29.5% YoY₹32 Cr
Reported PAT · +27.9% YoYFlat
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue grew 28% YoY, EBITDA 40%+ YoY
METRevenue +29.5% YoY, EBITDA margin 26.0% (flat vs delivered), strong growth confirmed
Enterprise Solutions grew 50% YoY, Services 5% YoY
METEnterprise 50% includes ~13% Cryptas (inorganic), ~25% organic; Services 5% organic, no headwind
Trust Services decline temporary, normalize by September
PartialDecline from ₹5-7 Cr token volume loss; normalized margin ~10%, limited PAT impact, recovery timing unconfirmed
Cryptas expected profitable in FY27
OVERSTATEDStill recording ₹4 Cr subsidiary losses; two wins (data center, municipality) cited as foundation, but profitability contingent on future product substitution sales
International margin headwinds temporary, offset by Cryptas profitability
OVERSTATEDInternational segment margin ~20% in Q1; Cryptas unprofitable, new senior hires (USD 200-300k each) will continue to pressure margins
Earnings quality
What changed since the last call
Guidance maintained despite Q1 beat
NeutralFY27 organic 18% and PAT 25% reaffirmed; no upgrade despite Q1 organic 25% and PAT 27.9%, signaling management expects headwinds (Trust Services recovery, Cryptas execution risk, macro caution)
3-year PAT doubling articulated in detail
UpgradeFirst formal disclosure: 2x PAT by FY29 via 18–20% organic revenue growth + margin expansion from 16% to 17–18%. Depends on Enterprise mix shift (20–25% growth) and Trust Services recovery (15–20% growth)
Cryptas transition from loss-making to product substitution
UpgradeTwo wins (German data center, Austrian municipality) now sell eMudhra stack (CertiNext, emSigner) instead of third-party products; replaces Keyfactor license costs with transfer pricing to India
Trust Services characterized as temporary decline
NeutralDown ₹5–7 Cr due to legacy token de-stocking; normalized by Sep 2026, but Q2 headwind acknowledged ('top-line may continue to be less'); margin impact minimal due to 10% gross margin
New product roadmap (PrivaTrust, CBOM, AI-emSigner) disclosed
NeutralEarly-stage launches with unquantified revenue impact; PrivaTrust focused on India DPDP Act compliance (deadline year-end 2026), timeline to international expansion vague
The Q&A
Analysts pressed on Cryptas profitability (contingent on wins), international margin recovery (dependent on volume), and new product TAM (Agentic AI early-stage). Management direct on numbers but cautious on timing; no pushback on sequential revenue decline (-1.4% QoQ) noted.
PrivaTrust roadmap & TAM — Surbhi Soni, Bellwether Capital
PartialConsent management live, pilots ongoing. DPDP Act compliance deadline year-end/next year; discovery & classification modules launching soon. India focus initially; international rollout after foothold (quarterly visibility expected in 1–2 quarters).
UAE Trust Service license timeline & scope — Surbhi Soni, Bellwether Capital
AnsweredQ1/Q2 FY27 completion. Enterprise-oriented eSign, local identity ecosystem, banking/segments focus. Complements emSigner offering in UAE via phased bank/entity embedding.
Trust Services token supply headwinds resolution — Surbhi Soni, Bellwether Capital
AnsweredePass token recertification pending (mostly by Sep 2026); innate token capacity low. Partners not stocking due to Sep expiry. Top-line impact continues Q2, but net margin unaffected (10% gross margin).
International segment profitability trajectory — Pankaj Sachdeva, Avis Capital
PartialMix: services 18–20%, Cryptas unprofitable (improving), own products better than India. Senior hires (USD 200–300k) add costs; profitability improves as Cryptas turns profitable and volume rises. No specific margin target for FY27 given.
Cryptas profitability in FY27 — Pankaj Sachdeva, Avis Capital
PartialLosses from B.V. (European HQ); Cryptas under B.V. When Cryptas profitable, B.V. becomes profitable. First two wins (CertiNext, emSigner) validate product substitution; 'very confident' of FY27 profitability but contingent on wins.
U.S. Products business outlook & pipeline — Srinath V, Bellwether Capital
PartialEnterprise segment growing 25%; In-Common (universities) active, 1,000–1,500 certificates/day issued. IoT/PKI, SSL/post-quantum trends creating awareness. Positive outlook but pipelines take time in North America.
SecurePass growth & deal value opportunity — Srinath V, Bellwether Capital
AnsweredDriven by Central Bank/capital markets regulator mandates, PAM/PIM adoption post-breaches. Deal values ₹4–6 Cr per bank; growing internationally (Philippines, Indonesia, Africa, Middle East). Defense also customer (200 applications deployed).
Cryptas product integration & cost savings — Srinath V, Bellwether Capital
AnsweredIntegration effort (6–7 months) substituting third-party Keyfactor with eMudhra CLM/CA. Cost savings from transfer pricing and license replacement. All IP dev continues from India.
Enterprise organic growth breakdown — Amit Chandra, HDFC Securities
AnsweredCryptas ₹20 Cr (~25% of base ₹80 Cr); organic 25%. Data centers require access control, critical infrastructure security; large TAM. First German data center win validates product-market fit.
Agentic AI opportunity & revenue capture — Amit Chandra, HDFC Securities
DodgedAI trust/governance critical for agent identity and traceability. CertiNext, SecurePass being strengthened. Early-stage conversations; pilots expected; looking at U.S. startup M&A for Agentic AI security. No revenue yet.
EBITDA margin bridge & sustainability — Amit Chandra, HDFC Securities
AnsweredLower token sales (lower margin), higher Enterprise % (higher margin). Offset by senior hires and geographic expansion. Sustainable range ~25% EBITDA, ~16–16.5% PAT as volumes improve.
FY30 vision & revenue mix evolution — Kanishk Gupta, SS Family Office
PartialNo FY30 view. 3-year vision: 2x PAT by FY29 via 18–20% organic growth + acquisitions (selective). Enterprise 20–25% growth, Trust 15–20%, Services negligible. Order book metric key (disclosed annually).
ROE/ROCE sustainability vs. peers — Kanishk Gupta, SS Family Office
AnsweredROE ~14.5–15% sustainable; peers similar or lower. No high leverage strategy; prefer low debt, avoid burden. Profit growth increases reserve, diluting ROE. Return profile better than foreign peers (many zero-margin).
TI Infotech legal case update — Sanjyot Khare, Vision Finance
AnsweredNo update. Police took statement Monday, have evidence. Outcome in police hands; unclear timeline. Company side fully documented.
Capital MXT stake in CI Infotech — Sanjyot Khare, Vision Finance
AnsweredPersonal investment, not related to eMudhra.
Service segment margins & profitability — Ravi Mehta, One Up Financial Consultants
PartialMargins not called out; broadly historical profile (likely 18–20%). Same as prior years.
Guidance
FY27 organic growth 18% (unchanged from prior call)
HighQ1 delivered 25% organic, but guidance maintained, signaling mgmt expects moderation (Trust Services recovery uncertainty, Cryptas profit contingency). Achievable but conservative.
EBITDA 25%, PAT 16–16.5% sustainable going forward
MediumQ1 achieved 26.2% EBITDA, 16.6% PAT; mgmt expects normalization as senior hires & geographic expansion offset token margin loss. Margin range implies modest expansion potential.
No explicit CapEx guidance; implied by 18–20% organic growth and international infrastructure buildout
LowThree data center locations in U.S., UAE launch, European sales hires; no quantified CapEx intensity disclosed
Risks the call surfaced
Trust Services recovery timing
Medium₹5–7 Cr token volume loss from legacy de-stocking; Q2 top-line expected to remain lower. Recovery assumes Sep 2026 FIPS 140-3 transition completes smoothly; new tokens (innate) capacity constrained.
Cryptas profitability contingency
HighCryptas still loss-making (₹4 Cr B.V. subsidiary losses). Profitability depends on selling eMudhra product stack instead of third-party Keyfactor. Two wins (German data center, Austrian municipality) validate strategy but early-stage.
International margin dilution
MediumInternational margins ~20% (Q1) vs. domestic 26%, driven by Cryptas losses + senior hire costs (USD 200–300k per person). Recovery timeline unclear; contingent on Cryptas turnaround & volume scale.
Sequential revenue decline unaddressed
MediumQ1 delivered ₹190.7 Cr; implied Q4 FY26 ~₹193.4 Cr (QoQ -1.4%). Trust Services explains ₹5–7 Cr loss (~2.8–3.6%), leaving 1–2% organic softness unexplained. Not discussed on call.
New product revenue uncertainty
MediumPrivaTrust (DPDP Act, consent management) launched commercially; CBOM analysis added to CertiNext; AI-powered emSigner in progress. Unquantified revenue impact; PrivaTrust timeline to international adoption vague ('quarter or two' for direction visibility).
Agentic AI opportunity timing
LowManagement sees structural tailwind in Agentic AI requiring agent identity & traceability (certificates, signatures). Currently early conversations; revenue impact zero. Bolt-on M&A being evaluated but market competitive/priced high.
Management
Score 7/10. Direct on quantified metrics (Cryptas ₹20 Cr, token margin 10%, losses ₹4 Cr); transparent on headwinds (Trust Services, international margins). Did not proactively explain QoQ revenue decline (-1.4%), suggesting selective disclosure. Clear roadmap but hedged on new product TAM. Track record solid: IPO 2022, maintained profitability, acquired Cryptas (first loss-making integration). Q1 beat estimates (29.5% vs. 15–18% guide, 27.9% PAT vs. 25–30%), but maintained guidance suggests caution or execution risk awareness.
1 · Sep 2026
Token standard FIPS 140-3 transition complete; Trust Services demand expected to normalize
2 · Q1/Q2 FY27
UAE QTSP Trust Service license approval; enterprise eSign launch (Aadhaar-equivalent market)
3 · FY27 H2
Cryptas profitability inflection on product substitution wins (CertiNext replacing Keyfactor); European customer base cross-sell
Long-term 2x PAT vision credible but relies on margin expansion and unproven new products (PrivaTrust, CBOM).